Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s share price shot up 9.1% during trading on Monday . The stock traded as high as $0.46 and last traded at $0.17. 1,934 shares changed hands during trading, a decline of 90% from the average session volume of 20,342 shares. The stock had previously closed at $0.15.
Cell MedX Stock Performance
The firm has a 50-day moving average of $0.39 and a 200 day moving average of $0.21.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Recommended Stories
- Five stocks we like better than Cell MedX
- What is the S&P 500 and How It is Distinct from Other Indexes
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- How to Invest in Blue Chip Stocks
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- Where Do I Find 52-Week Highs and Lows?
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
